智通财经APP获悉，巨子生物(02367)再涨超5%，截至发稿，涨4.87%，报57.05港元，成交额4409.96万港元。
消息面上，魔镜数据显示，巨子生物旗下可复美品牌的美容护肤品类2024年在天猫淘宝渠道的GMV增速高达42%，在猫淘渠道排名第二，仅次于儒意。招银国际指出，2024年收官，可复美和可丽金线上GMV增长亮眼。公司上调2024年业绩指引，预期收入增长50+%，归母净利润增长40%左右。
花旗也表示，预计巨子生物2024年收入将同比增52%，净利润同比增40%，与管理层指引增长一致。同时预计，2025-2026年净利润将分别增27%/21%，因受惠于收入增长分别30%/26%。因此，考虑到巨子生物2024年4月配股后股权被轻微摊薄，花旗预计集团3年净利润复合年增长率为29%，每股盈利复合年增长率为28%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.